Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shashank R Joshi

Showing results (91-100 of 178) with videos related to

Pageof 18
Sort By:
Expert Opinion on Pharmacotherapy|June 9, 2016
Effect of micronized fenofibrate on microvascular complications of type 2 diabetes: a systematic reviewLeszek Czupryniak, Shashank R Joshi, Jaideep A Gogtay, et al.
The Lancet Regional Health. Southeast Asia|April 20, 2026
Glycated haemoglobin for diagnosing and monitoring diabetes in Indian populations-authors' replyShambo Samrat Samajdar, Shashank R Joshi, Anoop Misra, et al.
The Lancet Regional Health. Southeast Asia|April 27, 2026
Corrigendum to "The limitations and fallacies of relying on glycosylated haemoglobin for diagnosing and monitoring diabetes in Indian populations" [The Lancet Regional Health - Southeast Asia Volume 45, February 2026, 100724]Shambo Samrat Samajdar, Shashank R Joshi, Anoop Misra, et al.
The Lancet Regional Health. Southeast Asia|February 26, 2026
The limitations and fallacies of relying on glycosylated hemoglobin for diagnosing and monitoring diabetes in Indian populationsShambo Samrat Samajdar, Shashank R Joshi, Anoop Misra, et al.
The Journal of the Association of Physicians of India|July 3, 2020
Hydroxychloroquine for COVID-19: What is our Current State of Knowledge?Zarir F Udwadia, Ketan N Malu, Divyanshi Rana, et al.
Indian Journal of Endocrinology and Metabolism|December 7, 2011
The Screening India's Twin Epidemic: Study design and methodology (SITE-1)Shashank R Joshi, Muruga Vadivale, Jamshed J Dalal, et al.
The Journal of the Association of Physicians of India|October 1, 2008
Challenges in diabetes care in India: sheer numbers, lack of awareness and inadequate controlShashank R Joshi, A K Das, V J Vijay, et al.
The Journal of the Association of Physicians of India|October 21, 2016
A Prospective Analysis of the Efficacy and Safety of Sodium Glucose Cotransporter 2 Inhibitors: Real World Evidence from Clinical Practice in IndiaBhavana Sosale, Aravind R Sosale, Prassanna M Kumar, et al.
The Journal of the Association of Physicians of India|September 12, 2007
Induction of long-term glycemic control in type 2 diabetic patients using pioglitazone and metformin combinationVijay Panikar, Shashank R Joshi, A Bukkawar, et al.
The Journal of the Association of Physicians of India|July 1, 2020
Prognostic Factors for Adverse Outcomes in COVID-19 InfectionZarir F Udwadia, Awatansh R Tripathi, Viral J Nanda, et al.
Pageof 18

Showing results (91-100 of 178) with videos related to

Sort By:
Pageof 18
Expert Opinion on Pharmacotherapy|June 9, 2016
Effect of micronized fenofibrate on microvascular complications of type 2 diabetes: a systematic reviewLeszek Czupryniak, Shashank R Joshi, Jaideep A Gogtay, et al.
The Lancet Regional Health. Southeast Asia|April 20, 2026
Glycated haemoglobin for diagnosing and monitoring diabetes in Indian populations-authors' replyShambo Samrat Samajdar, Shashank R Joshi, Anoop Misra, et al.
The Lancet Regional Health. Southeast Asia|April 27, 2026
Corrigendum to "The limitations and fallacies of relying on glycosylated haemoglobin for diagnosing and monitoring diabetes in Indian populations" [The Lancet Regional Health - Southeast Asia Volume 45, February 2026, 100724]Shambo Samrat Samajdar, Shashank R Joshi, Anoop Misra, et al.
The Lancet Regional Health. Southeast Asia|February 26, 2026
The limitations and fallacies of relying on glycosylated hemoglobin for diagnosing and monitoring diabetes in Indian populationsShambo Samrat Samajdar, Shashank R Joshi, Anoop Misra, et al.
The Journal of the Association of Physicians of India|July 3, 2020
Hydroxychloroquine for COVID-19: What is our Current State of Knowledge?Zarir F Udwadia, Ketan N Malu, Divyanshi Rana, et al.
Indian Journal of Endocrinology and Metabolism|December 7, 2011
The Screening India's Twin Epidemic: Study design and methodology (SITE-1)Shashank R Joshi, Muruga Vadivale, Jamshed J Dalal, et al.
The Journal of the Association of Physicians of India|October 1, 2008
Challenges in diabetes care in India: sheer numbers, lack of awareness and inadequate controlShashank R Joshi, A K Das, V J Vijay, et al.
The Journal of the Association of Physicians of India|October 21, 2016
A Prospective Analysis of the Efficacy and Safety of Sodium Glucose Cotransporter 2 Inhibitors: Real World Evidence from Clinical Practice in IndiaBhavana Sosale, Aravind R Sosale, Prassanna M Kumar, et al.
The Journal of the Association of Physicians of India|September 12, 2007
Induction of long-term glycemic control in type 2 diabetic patients using pioglitazone and metformin combinationVijay Panikar, Shashank R Joshi, A Bukkawar, et al.
The Journal of the Association of Physicians of India|July 1, 2020
Prognostic Factors for Adverse Outcomes in COVID-19 InfectionZarir F Udwadia, Awatansh R Tripathi, Viral J Nanda, et al.
Pageof 18